A recent AMR Research and Model N Life Science Survey has revealed critical areas of concern in the compliance and revenue planning processes of Life Science manufacturers.

Join AMR Research, Sepracor, and Model N on January 23 at 10 a.m. PST for a Web Seminar that will examine results from this survey and explore what finance leadership can do to reduce risk in today’s intense regulatory climate. Register Today

Speakers

Hussain Mooraj, Research Director, AMR Research Hussain Mooraj brings more than a decade of experience in pharmaceutical and biotech consulting, strategic consulting, and marketing to his role as a research director at AMR Research. As part of the Value Chain Strategies team, he currently focuses his research on the pharmaceutical (branded & generic), biotech, medical device, and wholesale distribution business segments.

Anne Flaherty, Senior Director, Government Pricing, Compliance and Administration, Sepracor
Anne Flaherty is an expert in operations management, price reporting, rebate and contract management, financial accounting, reimbursement, contract management, legislative affairs, and strategic planning. At Sepracor, she is responsible for all federal and state pricing, government rebate management, VA contract compliance, and related forecast and accruals.

Moderator

Gopkiran Rao, Senior Director, Life Sciences Industry Marketing, Model N
Gop Rao brings extensive knowledge of Revenue Management best practices garnered from leading value assessment, product definition, and services implementations for medical technology and pharmaceutical companies. In his current role, he is responsible for the go-to-market strategy for Model N’s life sciences vertical.